V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001979 | 250004231 | 1.72 | 90 | null | 2017-12-28 | 2018-02-05 | null | 02 | null | CARBOPLATIN + VINORELBINE | 101693136 |
| 250001984 | 250004234 | 1.67 | 63.4 | null | 2019-03-20 | 2019-03-20 | Carboplatin + Pemetrexed | 02 | null | PACLITAXEL | 101536235 |
| 250001985 | 250004235 | 1.72 | 80 | null | 2019-06-18 | 2019-10-23 | Trial Unspecified | 02 | N | CARBOPLATIN + FLUOROURACIL | 100468811 |
| 250001987 | 250004236 | null | null | Neo-adjuvant (N) | null | 2019-01-23 | Oxaliplatin + Modified de Gramont | null | N | TRIAL UNSPECIFIED | 101453197 |
| 250001988 | 250004237 | 1.73 | 96.6 | null | 2017-11-28 | 2017-12-07 | Panitumumab | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100783394 |
| 250001990 | 250004239 | null | null | Palliative (P) | 2019-06-05 | 2019-07-07 | Carboplatin + Pemetrexed | 02 | null | CAPMATINIB | 101325497 |
| 250001993 | 250004242 | 1.74 | 12.45 | Palliative (P) | 2019-11-14 | 2019-11-27 | CARBOPLATIN + PACLITAXEL | 02 | null | DOXORUBICIN | 100496697 |
| 250001995 | 250004244 | 1.75 | 146 | null | 2017-12-17 | 2017-12-18 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100349034 |
| 250002001 | 250004249 | 1.75 | 104.4 | Palliative (P) | 2019-07-17 | 2019-09-18 | null | 02 | null | DOCETAXEL | 100842351 |
| 250002003 | 250004251 | null | null | null | 2018-05-07 | 2018-06-04 | Doxorubicin + Olaratumab | 01 | null | ETOPOSIDE + IFOSFAMIDE | 100155505 |
| 250002005 | 250004253 | 1.75 | 24.1 | Palliative (P) | 2019-02-18 | 2019-03-04 | null | 02 | null | TIVOZANIB | 100520456 |
| 250002009 | 250004257 | 1.56 | 71.1 | null | 2021-06-03 | 2021-06-03 | null | 02 | null | DOXORUBICIN | 100776673 |
| 250002018 | 250004262 | 1.75 | 86.8 | Palliative (P) | 2017-06-12 | 2017-06-13 | Ipilimumab | 02 | N | CISPLATIN + PEMETREXED | 101231088 |
| 250002019 | 250004263 | 1.85 | 62.2 | null | 2019-10-21 | 2020-08-25 | null | 02 | N | BEVACIZUMAB | 100506955 |
| 250002021 | 250004265 | null | null | Palliative (P) | null | 2018-06-02 | WT SIOP 2002 01 post op Vinc alone | null | null | IPILIMUMAB + NIVOLUMAB | 101285090 |
| 250002036 | 250004273 | null | null | null | null | 2018-05-02 | Oxaliplatin + Modified de Gramont | null | N | PACLITAXEL | 101318145 |
| 250002046 | 250004280 | 1.67 | 71.7 | Palliative (P) | 2021-02-18 | 2021-04-23 | Capecitabine (21 day) + Irinotecan | N | null | CAPECITABINE + OXALIPLATIN | 101343450 |
| 250002050 | 250004282 | 0.9 | 79 | Palliative (P) | 2018-04-20 | 2018-05-05 | null | N | null | CARBOPLATIN + FLUOROURACIL | 100700914 |
| 250002058 | 250004290 | 1.71 | 67.45 | null | null | 2019-05-22 | Docetaxel | null | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101563165 |
| 250002059 | 250004291 | 1.62 | 31.1 | null | 2019-05-31 | 2019-05-31 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN | 100232944 |
| 250002061 | 250004293 | null | null | null | 2019-11-23 | 2019-12-21 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100867497 |
| 250002064 | 250004296 | null | null | null | null | 2017-08-25 | null | null | null | ECX | 101231921 |
| 250002066 | 250004298 | 0 | 78.2 | null | 2017-08-24 | 2017-09-28 | Tivozanib | 02 | N | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100172817 |
| 250002067 | 250004299 | null | null | null | 2019-05-06 | 2019-07-07 | GEMCITABINE + RT | 01 | null | ENZALUTAMIDE | 100551901 |
| 250002069 | 250004301 | 1.6 | 52.9 | Palliative (P) | 2019-07-04 | 2019-07-18 | Docetaxel | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100019413 |
| 250002076 | 250004306 | null | null | Palliative (P) | null | 2019-03-18 | Irinotecan + Modified De Gramont | null | N | DOCETAXEL + GEMCITABINE | 100996042 |
| 250002078 | 250004308 | 1.85 | 92 | Palliative (P) | 2019-02-11 | 2019-02-12 | null | 02 | N | IMATINIB | 100686510 |
| 250002079 | 250004309 | 0 | 83.3 | Curative (C) | 2017-08-28 | 2017-08-29 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100925245 |
| 250002081 | 250004311 | 1.49 | 54.4 | 02 | 2018-07-23 | 2018-08-15 | null | 02 | null | CAPECITABINE + IRINOTECAN | 101847557 |
| 250002083 | 250004313 | null | null | null | null | 2019-07-31 | null | null | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101586927 |
| 250002089 | 250004317 | null | null | null | null | 2019-11-03 | AVELUMAB + AXITINIB | null | null | FLUOROURACIL + MITOMYCIN | 101537663 |
| 250002090 | 250004318 | null | null | null | 2016-05-07 | 2016-06-22 | Trial Unspecified | 01 | N | PACLITAXEL | 101042099 |
| 250002092 | 250004320 | 1.51 | 60 | Palliative (P) | 2020-01-08 | 2020-01-08 | null | 01 | N | DOXORUBICIN | 101264613 |
| 250002098 | 250004322 | null | null | null | 2019-07-30 | 2019-07-30 | Pazopanib | 02 | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101189822 |
| 250002101 | 250004325 | 1.57 | 49.6 | null | 2018-07-03 | 2018-07-03 | CAPECITABINE + OXALIPLATIN | 02 | N | ATEZOLIZUMAB | 101142337 |
| 250002103 | 250004326 | null | null | null | null | 2018-12-24 | Trial Unspecified | null | null | FLUOROURACIL + IRINOTECAN | 101790789 |
| 250002104 | 250004327 | 1.75 | 93.1 | Palliative (P) | 2019-02-07 | 2019-02-07 | Trial Unspecified | null | Y | NB HRNBL-1 COJEC IND COURSE C | 101714991 |
| 250002105 | 250004328 | 1.88 | 46.6 | null | 2019-04-12 | 2019-04-18 | Trial Unspecified | 02 | N | PAZOPANIB | 100926058 |
| 250002106 | 250004329 | null | null | null | null | 2018-11-11 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 101285689 |
| 250002107 | 250004330 | 1.81 | 42 | Palliative (P) | 2019-04-10 | 2019-04-25 | null | 02 | null | CARBOPLATIN | 100626278 |
| 250002109 | 250004332 | 1.82 | 89.9 | Palliative (P) | 2018-10-03 | 2018-10-05 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101399827 |
| 250002111 | 250004334 | 1.7 | 70 | Palliative (P) | 2018-09-18 | 2018-11-11 | Trial Unspecified | 01 | null | NB HRNBL-1 COJEC IND COURSE C | 100056306 |
| 250002115 | 250004337 | 1.7 | 77.2 | Palliative (P) | 2018-09-28 | 2018-10-07 | Trial Unspecified | 02 | N | ENZALUTAMIDE | 101274992 |
| 250002117 | 250004339 | null | null | Palliative (P) | null | 2019-01-12 | Pazopanib | null | null | FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 100251207 |
| 250002122 | 250004344 | 1.56 | 56.8 | Neo-adjuvant (N) | 2018-11-15 | 2018-11-24 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | PACLITAXEL | 101087243 |
| 250002123 | 250004345 | 1.65 | 0 | null | 2017-02-15 | 2017-02-15 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | IMATINIB | 101069749 |
| 250002128 | 250004349 | 1.56 | 89.7 | null | 2018-03-07 | 2018-03-08 | STS Rhabdo VIT0910 Vinc Irinotecan | 01 | null | CISPLATIN | 101714527 |
| 250002131 | 250004352 | null | null | Palliative (P) | 2019-11-30 | 2019-12-01 | VINCRISTINE | 02 | N | CISPLATIN + RT | 100919250 |
| 250002142 | 250004360 | null | null | Palliative (P) | 2022-04-11 | 2022-04-11 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100480356 |
| 250002148 | 250004364 | 1.78 | 58.9 | null | null | 2017-02-06 | VINORELBINE | null | null | ATEZOLIZUMAB | 101776024 |